Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 08
2023
|
David P Schenkein Director |
BUY
Grant, award, or other acquisition
|
Direct |
240
+50.0%
|
-
|
Sep 08
2023
|
Kathryn Guarini Director |
BUY
Grant, award, or other acquisition
|
Direct |
240
+50.0%
|
-
|
Sep 01
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
250
-1.25%
|
$208,500
$834.55 P/Share
|
Aug 24
2023
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
6,197
-2.46%
|
$5,199,283
$839.93 P/Share
|
Aug 23
2023
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
16,928
-37.93%
|
$14,253,376
$842.66 P/Share
|
Aug 23
2023
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
23,125
+34.13%
|
$8,810,625
$381.4 P/Share
|
Aug 23
2023
|
Christine A Poon Director |
SELL
Open market or private sale
|
Direct |
12,280
-26.61%
|
$10,302,920
$839.53 P/Share
|
Aug 23
2023
|
Christine A Poon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,280
+46.17%
|
$3,352,440
$273.67 P/Share
|
Aug 23
2023
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
223
-0.7%
|
$188,212
$844.0 P/Share
|
Aug 23
2023
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,198
-19.89%
|
$4,376,716
$842.66 P/Share
|
Aug 23
2023
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+21.12%
|
$2,793,000
$399.66 P/Share
|
Aug 22
2023
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
11,665
-6.34%
|
$9,810,265
$841.37 P/Share
|
Aug 21
2023
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
853
-40.62%
|
$707,137
$829.0 P/Share
|
Aug 21
2023
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
853
+28.89%
|
$333,523
$391.92 P/Share
|
Aug 21
2023
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
38,335
-37.18%
|
$31,933,055
$833.39 P/Share
|
Aug 21
2023
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+32.66%
|
$19,950,000
$399.66 P/Share
|
Aug 10
2023
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
853
-40.62%
|
$673,017
$789.0 P/Share
|
Aug 10
2023
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
853
+28.89%
|
$333,523
$391.92 P/Share
|
Aug 01
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$73,700
$737.75 P/Share
|
Aug 01
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
250
-1.23%
|
$186,000
$744.66 P/Share
|
Jul 03
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$71,500
$715.83 P/Share
|
Jul 03
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
250
-1.22%
|
$177,500
$710.09 P/Share
|
Jun 01
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
250
-1.2%
|
$184,000
$736.0 P/Share
|
Jun 01
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$73,400
$734.44 P/Share
|
May 15
2023
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
BUY
Bona fide gift
|
Indirect |
53,807
+45.3%
|
-
|
May 15
2023
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Bona fide gift
|
Indirect |
53,807
-100.0%
|
-
|
May 09
2023
|
Andrew J Murphy EVP Research |
SELL
Bona fide gift
|
Direct |
1,326
-2.18%
|
-
|
May 01
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.08%
|
$80,500
$805.46 P/Share
|
Apr 21
2023
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
3,070
-71.11%
|
$2,449,860
$798.42 P/Share
|
Apr 21
2023
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,070
+41.56%
|
$1,596,400
$520.01 P/Share
|
Apr 03
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.02%
|
$899,800
$818.8 P/Share
|
Apr 03
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+4.78%
|
$409,200
$372.46 P/Share
|
Apr 03
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.07%
|
$81,900
$819.99 P/Share
|
Apr 03
2023
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
259
-0.21%
|
-
|
Mar 28
2023
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
1,007
-0.39%
|
$827,754
$822.95 P/Share
|
Mar 27
2023
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
183
-0.07%
|
$150,792
$824.12 P/Share
|
Mar 27
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,793
-4.02%
|
$2,304,225
$825.17 P/Share
|
Mar 27
2023
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+5.1%
|
$1,444,000
$380.45 P/Share
|
Mar 24
2023
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,240
-49.86%
|
$1,014,320
$818.0 P/Share
|
Mar 24
2023
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,240
+33.27%
|
$471,200
$380.95 P/Share
|
Mar 23
2023
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Open market or private sale
|
Indirect |
3,656
-0.23%
|
$2,939,424
$804.29 P/Share
|
Mar 23
2023
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Direct |
25,000
-7.41%
|
-
|
Mar 23
2023
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
2,192
-10.64%
|
$1,766,752
$806.47 P/Share
|
Mar 23
2023
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
6,742
-19.71%
|
$5,400,342
$801.59 P/Share
|
Mar 23
2023
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+22.62%
|
$2,700,000
$270.43 P/Share
|
Mar 10
2023
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Bona fide gift
|
Indirect |
1,006
-100.0%
|
-
|
Mar 01
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.02%
|
$834,900
$759.89 P/Share
|
Mar 01
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+4.78%
|
$409,200
$372.46 P/Share
|
Mar 01
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$76,200
$762.44 P/Share
|
Feb 22
2023
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
29,005
-7.91%
|
$21,753,750
$750.16 P/Share
|